Sp1135
SURGICAL MANAGEMENT OF BILIARY AND INTESTINAL OBSTRUCTION BECAUSE OF PANCREATIC HEAD DISEASE
Date
May 21, 2024
Speaker
Johns Hopkins University
Tracks
Related Products
PERSISTENCE OF SPLANCHNIC GENE SIGNATURE DEFINES A TUMOR-RESTRAINING FIBROBLAST SUBTYPE IN PANCREATIC CANCER
The pancreas is composed of the epithelial and mesenchymal cells. Interaction between the two lineages guides proper formation of the pancreas and modulates progression of pancreatic diseases such as cancer…
RNA SEQUENCING FROM BIOPSIES PERFORMED DURING FOOD ELIMINATION AND REINTRODUCTION IDENTIFIES SIGNATURES INVOLVED IN EARLY RECURRENCE OF EOE
RATIONALE: RNA sequencing studies have previously identified impaired barrier function and the subsequent proinflammatory response as critical to the pathogenies of EoE. However, the investigation into disease initiation is often limited by the inability to capture the disease early…
SURVODUTIDE REDUCES LIVER FAT CONTENT, TRANSAMINASES, AND FIBROSIS MARKERS WITH GOOD SAFETY PROFILE IN PEOPLE WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS (MASH): AN INTERIM ANALYSIS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2 TRIAL
BACKGROUND: Survodutide is a novel glucagon receptor/glucagon-like peptide-1 receptor dual agonist under investigation for treatment in advanced liver disease associated with metabolic dysfunction-associated steatohepatitis (MASH), the most severe form of metabolic dysfunction-associated steatotic…
ROBOTIC LIVER RESECTION 4B/5, CYSTIC DUCT RESECTION, PORTAL LYMPH NODE DISSECTION FOR GALLBLADDER CANCER
Here we presented a case with an incidental diagnosis of gallbladder cancer after laparoscopic cholecystectomy. After three cycles of chemotherapy (gemcitabine and cisplatin), we performed a robotic partial liver resection (4b/5), cystic duct resection, portal lymph nodes resection…
